Radiopharmaceutical and biomarker development leader with a 30 year record of advancing first in human imaging agents, shaping regulatory strategy, and driving clinical translation for oncology, neurology, and inflammation therapeutics. Architect of large, complex radiopharmaceutical portfolios across academia, big pharma, and venture backed biotech. Tenured professor, prolific scientific author, and physician sponsor of more than […]
I am a translational R&D scientist and Scientific Director with over 15 years of experience developing therapies for rare neuromuscular and neurodegenerative disease. My expertise spans RNA-based therapeutics and gene therapy, from early discovery through clinical translation, with hands-on experience across academia and industry. My technical background includes antisense oligonucleotide (ASO) design and mechanism, exon-skipping […]
Thomas Brown, MD, MBA is Chief Medical Officer of Sygnomics, a startup applying systems biology & AI to help oncologists match cancer patients to personalized therapies. He is on the affiliate faculty at Institute for Systems Biology. He has more than two decades of oncology leadership spanning academic medicine, health-system administration, and health-tech innovation, including […]
Strategic life sciences leader with over 25 years of experience spanning R&D, global pharma and life science strategy consulting. Known for helping biotech and pharmaceutical companies make critical decisions about how to develop, prioritise and commercialise their assets. Brings a rare combination of scientific training, industry leadership and strategic advisory experience, enabling organisations to bridge […]
Dane Thomas is a nationally recognized Hematology/Oncology Physician Associate with over 15 years of experience in radiation oncology, medical oncology, and hematology. He currently practices at Texas Oncology, caring for patients across the full cancer continuum—from diagnosis through survivorship and advanced care planning. Dane is also a leader and educator in the oncology community. He […]
Kevin Heath, MD, MPH, FACP is a board-certified internist and nephrologist who has spent his career inside one of the largest payer-provider enterprises in the country. He now leads Heath Clinical Intelligence Advisory, providing consulting expertise at the intersection of clinical medicine, population health, and integrated payer-provider strategy.nnHis expertise spans clinical operations, quality of care, […]
I am a medical oncologist and drug developer dedicated to translating innovative science into breakthrough therapies for patients with cancer. As Executive Chair of Head & Neck Research at Sarah Cannon Research Institute, I am recognized as a key opinion leader in head & neck oncology, shaping the design and execution of early clinical development […]
Extensive experience in drug development and approval. Worked at US FDA from 1991 to 2017 and then as SVP and Head Regulatory Affairs for Anavex Life Science, NY from 2017-2022. Currently working as a Regulatory Consultant to pharmaceutical companies.
https://scholar.google.com/citations?user=V1LN5rkAAAAJ&hl=en
I am a senior biotech and pharma strategist with over 20 years of experience across medical affairs, clinical development, external innovation, portfolio strategy, and venture-facing due diligence. My background spans oncology, hematology, rare diseases, RNA therapeutics, CNS, dermatology, regenerative medicine, and longevity biology. I have held leadership roles in global and regional organizations, including Celgene, […]